Weizmann Institute

Ziv Shulman

Revealing the gut’s B-cell training program may point to new means of developing oral vaccines

Revealing the gut’s B-cell training program may point to new means of developing oral vaccines

04.03.2019

Systems Biology, Viruses & Microorganisms, Immunology, Disease, Drugs & Diagnostics

...

inhibition

Going for Strong Inhibition

31.01.2019

Biochemistry, Personalized Medicine, Systems Biology, Immunology, Disease, Drugs & Diagnostics, Bioinformatics and Computational Biology, Biotechnology, Diagnostic Techniques and Drugs

A unique method for identifying bioactive chemical compounds produces a potential new drug molecule

Dr. Ziv Shulman

Dr. Ziv Shulman

25.11.2018

Dr. Ziv Shulman has been elected as an EMBO Young Investigator

T cell and B cell with ICAMs

Choosing the Right Weapons against Pathogens

06.11.2017

Viruses & Microorganisms, Molecular and Cell Biology, Immunology

How low-affinity antibodies can still win in an immune system competition

Dr. Ziv Shulman

Dr. Ziv Shulman

06.04.2016

Dr. Ziv Shulman

...

Dr. Ziv Shulman

Blavatnik Award to Dr. Ziv Shulman

05.01.2016

...

Top Stories

See All >

CEST la vie: High-Powered Magnets Improve Early Detection of Cancer in Rats

Dr. Michal Leskes

Prof. Giora Mikenberg

Noam Stern-Ginossar and group

Host and Virus Face Off over RNA Modification

Press Releases

See All >

New Clinical Study Being Launched at the Weizmann Institute of Science

Same Microbe, Different Effect

Historic partnership between the Weizmann Institute of Science and Institut Curie

Most Popular Articles

Prof. Zvi Artstein, Vice President for Technology Transfer

Prof. Zvi Artstein

Israeli Researchers to Participate in European Commission Flagship

The European Commission has officially announced the selection of the Human Brain Project (HBP) as one of its two Future Emerging Technologies (FET) Flagship projects.

Let it Rain

Added particles in the atmosphere could be affecting rainfall patterns